Tap to enable a layout that focuses on the article.
Advertisement

ICN Pharmaceuticals confirmed earlier reports that it...

ICN Pharmaceuticals confirmed earlier reports that it is considering acquiring up to 25% of a West German pharmaceutical firm, Schering AG. The Costa Mesa company said in a statement that the move was part of a 3-year effort to expand its marketing capabilities.

Inside the business of entertainment

The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.

Advertisement
Advertisement